Education
About Us
Working with TipRanks
Follow Us
HeartFlow, Inc. (HTFL)
NASDAQ:HTFL
HTFL Stock Chart & Stats
$33.77
--
Market closed
$33.77
--
Day’s Range― - ―
52-Week Range$26.56 - $39.24
Previous CloseN/A
VolumeN/A
Average Volume (3M)378.20K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,396,100
10 Day Avg. Volume270,857
30 Day Avg. Volume378,204
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$36.60Price Target Upside8.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial PerformanceHeartflow is poised to deliver above-average growth and margin performance, with a projected 24% growth CAGR in the 2025-2028 period and potential gross margin expansion to 83%.
Market ExpansionThe company is minimally penetrated in the $3.1B coronary blood flow market and remains in the early launch stages of the $2.9B plaque analysis market and favorably positioned for continued share gains.
Product InnovationHeartflow's AI-based products are set to change the standard of care in the detection of coronary artery disease.
Bears Say
Reimbursement ChallengesHeartflow’s long-term sales growth will largely rely on expanding its hospital footprint and increasing utilization of CCTA across the U.S., and any changes to reimbursement codes could disincentivize adoption of Heartflow’s software solutions.
Valuation ConcernsHeartflow currently trades at a premium compared to other high growth medtech names, which is warranted given the company’s solid top-line growth outlook and improving margins driving solid profitability in the coming years.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $26.56 and its highest was $39.24 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
Currently, no data Available
When is HeartFlow, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HeartFlow, Inc.’s earnings last quarter?
Currently, no data Available
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 83,396,100 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
Company Description
HeartFlow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Stock 12 Month Forecast
Average Price Target
$36.60
▲(8.38% Upside)
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---